Poisoning & Drug Dependence

Extended-release buprenorphine not cost-effective when transmucosal buprenorphine is available for treatment of OUD.

The Company anticipates making the product available in the second half of 2024 or early 2025, if approval is granted.

Combination of a patch and fast-acting nicotine replacement therapy also effective.

Quarterly percentage of deaths more than doubled with evidence of counterfeit pill use from July to September 2019 to October to December 2021.

Brixadi (weekly) and Brixadi (monthly) are different formulations.

The manufacturer’s suggested retail price is $44.99 per carton.

THC ingestions of 1.7mg/kg or greater predicted severe and prolonged toxicity, with sensitivity of 97.3 and 75.4%, respectively.

Study shows that all behavioral outcomes favor e-cigarette users across the motivational spectrum for quitting.

Cytisinicline well tolerated with only 2.9% of participants discontinuing due to an adverse event.

Small proportion of people with sustained or increasing use were older, had more comorbidities, and used other analgesic drugs.

Recommendations include criteria for ED triage, laboratory evaluation and monitoring parameters, management of acetylcysteine treatment.

Medications for OUD more likely for those with severe vs mild past-year OUD, receiving substance use treatment via telehealth.

The product is a therapeutically equivalent version of Narcan® nasal spray.

Significantly increased risk observed for social or behavioral health workers, registered nurses, health care support workers.

Baseline alcohol intake associated with systolic BP changes in men and women, diastolic BP in men.

Each RiVive nasal spray unit contains 3mg of naloxone HCl and delivers a single dose.

The grants will help test for lead in drinking water, identify sources of contamination, and help fix the problem, agency says.

Naloxone hydrochloride nasal spray is indicated for the emergency treatment of known or suspected opioid overdose.

Age-adjusted rate of overdose deaths involving cocaine and opioids increased more quickly than cocaine alone from 2011 to 2021.